# Serina Therapeutics, Inc.: Form 8-K, filed Jun 24, 2026

- Company: [Serina Therapeutics, Inc.](/companies/ser.md) (CIK 1708599)
- Form: 8-K
- Filed: 2026-06-24
- Accepted by EDGAR: Jun 24, 2026, 16:10 ET
- Period: 2026-06-17
- Accession: 0001708599-26-000040
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1708599/000170859926000040/ser-20260617.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1708599/000170859926000040/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1708599/000170859926000040/ser-20260617.htm

Filed Jun 24, 2026.
Source: SEC EDGAR, the filing index for accession 0001708599-26-000040. Last ingested by Listed: Nov 13, 2026, 15:52 ET. No prices; not investment advice.